Abiopharma

🔍 Nalbandian Jason R (Executive)

Company: EMCOR Group, Inc. (EME)

Report Date: 2026-04-30

Detailed Transactions and Holdings:

• Acquired 4 shares of Common Stock (Direct)
  Date: 2026-04-30 | Code: A | equity_swap_involved: 0 | shares_owned_after: 18,957.00 | transaction_form_type: 4 | Footnotes: F1, F2

Footnotes:

• F1: Represents restricted stock units ("RSUs") issued in respect of already outstanding RSUs as a consequence of a dividend paid on the Company's common stock on April 30, 2026. The RSUs issued on April 30, 2026 are subject to the same vesting and forfeiture provisions as the RSUs in respect of which they have been issued.
• F2: Includes shares issuable in respect of RSUs.